Current problems of perinatal Chlamydia trachomatisinfections
Journal of Immune Based Therapies and Vaccines · 2004
DOI: 10.1186/1476-8518-2-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immune Based Therapies and Vaccines, 2004. Verfasst von Kei Numazaki. Beteiligte Einrichtung: Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan. numazaki@sapmed.ac.jp. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Chlamydia trachomatis has been recognized as a pathogen of trachoma, nongonococcal urethritis, salpingitis, endocervicitis, pelvic inflammatory disease, inclusion conjunctivitis of neonates, follicular conjunctivitis of adults, infantile pneumonia and associated conditions. Chlamydial infections during pregnancy may also cause a variety of perinatal complications. Different antigenic strains of C. trachomatis from endocervical, nasopharyngeal and conjunctival origins have been associated with different clinical conditions. Control programs emphasizing early diagnosis, targeted screening, and effective treatment will lead to an eventual decline in the incidence of perinatal chlamydial infection. This review focuses on current problems of perinatal C. trachomatis infections in the aspects of microbiological and immunological pathogenesis.
Autor:innen und Institutionen
- Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan. numazaki@sapmed.ac.jp
Zitieren
APA
Numazaki, K. (2004). Current problems of perinatal Chlamydia trachomatisinfections. Journal of Immune Based Therapies and Vaccines. https://doi.org/10.1186/1476-8518-2-4
Vancouver
Numazaki K. Current problems of perinatal Chlamydia trachomatisinfections. Journal of Immune Based Therapies and Vaccines. 2004. doi:10.1186/1476-8518-2-4
BibTeX
@article{Numazaki2004,
author = {Numazaki, Kei},
title = {Current problems of perinatal Chlamydia trachomatisinfections},
journal = {Journal of Immune Based Therapies and Vaccines},
year = {2004},
doi = {10.1186/1476-8518-2-4}
}
EUVIMED